Login/Register
Pfizer-BioNtech seeks approval for third dose of COVID-19 vaccine
The Pfizer-BioNtech COVID-19 vaccine may require a third dose to work more effectively against the coronavirus (Covid-19). The third Covid-19 shot is also expected to provide better protection against the beta variant. American pharmaceutical company Pfizer-BioNtech is trying to get approval for the third dose. The company claims that a third dose may be needed to beat Corona. The company will try to get approval in view of the interim trial data, which showed that the third dose can increase antibody levels by five to ten times compared to the first two doses. In fact, this third Covid-19 dose is
Central Government Launches “Mission Covid Suraksha”
The central government has launched ‘Mission Covid Suraksha’ to facilitate the development of around 5-6 Covid-19 vaccines. According to the Department of Biotechnology (DBT) of the Government of India, this will also ensure that, various vaccines are offered for market introduction and licensing. DBT further noted that, this mission focuses on the preclinical phase as well as clinical development, through the manufacturing and regulatory facility to the end of the Kovid-19 vaccine development. Earlier in November 2020, the Government of India announced a third incentive package of Rs 900 crore for the ‘Mission Covid Suraksha – Indian Covid-19 Vaccine Development
NDA After 10th
NDA (Offline & Online) Batch
SSB Interview (Offline & Online)
